Byron S. Cooper, M.D.

NPI 1164484341ActiveIndividual· Internal Medicine, Pulmonary Disease· Washington, DC

Internal Medicine, Pulmonary Disease (M.D.) in Washington, District of Columbia, trained at Washington University School of Medicine (class of 1973). Their prescriptions cost Medicare Part D more than their services did: $60,090 for 154 claims, against $39,505 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 8 companies reporting payments in 2025, $840.25 in all, mostly food and beverage.

Overview

NPI	1164484341
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Apr 4, 2006
Last updated in NPPES	Apr 30, 2011

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	MD12803	DC
Internal Medicine	207R00000X	MD12803	DC

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (DC); Practitioner - Pulmonary Disease (MD)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	169
Services billed	655 across 36 procedure codes
Paid by Medicare	$39,505

Part D prescriptions in 2024

Prescriptions (claims)	154 · 291 30-day fills
Patients	59
Total drug cost	$60,090
Generic share	79% of claims

Medicare sources and data years

Education and affiliations

Medical school	Washington University School of Medicine
Graduation year	1973
Medicare specialty	Pulmonary Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth